One BioMed

We are a molecular life science company at the forefront of innovation, transforming human health by accelerating the pace of biomedical research and testing. We are focused on accelerating and decentralizing molecular research and testing by providing biomedical researchers with unprecedented access to cutting-edge tools. One BioMed is a rapidly growing startup at the forefront of innovation. It’s an exciting time to join One BioMed as we commercialize our first product line. Mi Kyoung Park, is the Founder & CEO of One BioMed. As the COO, Nick took Strategene public and led the charge at Agilent as President of its Life Science division. Min Suk is the Managing Director of Mirae-N Singapore and Nvestor, a venture capital and private equity firm based in Seoul, South Korea. David Ludvigson, is the CEO at Nanomix, a point-of-care diagnostic medical device company, headquartered in Emeryville, California.